scholarly journals A Lot to a Little or a Little to a Lot—Which Dose-Volume Relationship Ensures the Best Clinical Outcome in the High-Dose Radiation Therapy of Thoracic Tumors? A Prospective Approach

2016 ◽  
Vol 96 (2) ◽  
pp. E439
Author(s):  
C. Schroeder ◽  
R. Engenhart-Cabillic ◽  
A. Buchali
Keyword(s):  
Radiation Therapy ◽  
Clinical Outcome ◽  
High Dose ◽  
Dose Volume ◽  
Volume Relationship ◽  
Dose Radiation

scholarly journals A lot to a little or a little to a lot—which dose-volume relationship ensures the best clinical outcome in the high dose radiation therapy of thoracic tumors? A prospective approach

2016 ◽  
Vol 8 (8) ◽  
pp. 2053-2060 ◽  
Author(s):  
Christina Schröder ◽  
Rita Engenhart-Cabillic ◽  
Hilke Vorwerk ◽  
Michael Schmidt ◽  
Winfried Huhnt ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Clinical Outcome ◽  
High Dose ◽  
Dose Volume ◽  
Volume Relationship ◽  
Dose Radiation

Pancoast Tumor: The Value of High Dose Radiation Therapy

Radiology ◽  
1979 ◽  
Vol 132 (3) ◽  
pp. 717-719 ◽  
Author(s):  
R. William Morris ◽  
Rushdy Abadir
Keyword(s):  
Radiation Therapy ◽  
High Dose ◽  
Pancoast Tumor ◽  
Dose Radiation

Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study

2020 ◽  
Vol 10 (4) ◽  
pp. e255-e263 ◽  
Author(s):  
Bram D. Vermeulen ◽  
Paul M. Jeene ◽  
Jasmijn Sijben ◽  
Robin Krol ◽  
Heidi Rütten ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Radiation Therapy ◽  
Cohort Study ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Low Dose ◽  
High Dose ◽  
Dose Radiation

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

2012 ◽  
pp. 261-264 ◽  
Author(s):  
Laura A. Dawson ◽  
Sameh Hashem ◽  
Alexis Bujold
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiation Therapy ◽  
Liver Function ◽  
Randomized Trials ◽  
Stereotactic Body Radiation Therapy ◽  
Great Majority ◽  
High Dose ◽  
Dose Volume ◽  
Systemic Therapies

Overview: Stereotactic body radiotherapy (SBRT), in which highly conformal potent radiation doses are delivered in fewer fractions than traditional radiation therapy (RT), is an increasingly popular treatment for hepatocellular carcinoma (HCC). The great majority of HCCs smaller than 6 cm and with Child-Pugh A liver function are controlled with SBRT with limited toxicity. Long-term local control is reduced in larger tumors, and toxicity is increased in patients with Child-Pugh B or C liver function. SBRT is an effective treatment for tumor vascular thrombi and can lead to sustained vascular recanalization. The first site of recurrence following SBRT is most often within the liver, away from the high dose volume, providing rationale for combining SBRT with regional or systemic therapies. Randomized trials of SBRT are warranted.

Sign in / Sign up

Export Citation Format

Share Document